(Q38965279)

8 September 2017

title

In vitro susceptibility characteristics of Cryptococcus neoformans varieties from AIDS patients in Goiânia, Brazil (English)

1 reference

8 September 2017

0 references

Cryptococcus neoformans

1 reference

based on heuristic

inferred from title

author name string

Orionalda de F L Fernandes

1

1 reference

8 September 2017

Xisto S. Passos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595465

27 March 2024

Lúcia K. H. Souza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595465

27 March 2024

André T. B. Miranda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595465

27 March 2024

Carlos Henrique P. V. Cerqueira

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595465

27 March 2024

Maria do Rosário R. Silva

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14595465

27 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14595465

27 March 2024

publication date

1 September 2003

1 reference

8 September 2017

29 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14595465

full work available at URL

27 March 2024

published in

Memórias do Instituto Oswaldo Cruz

1 reference

8 September 2017

volume

98

1 reference

8 September 2017

issue

6

1 reference

8 September 2017

page(s)

839-841

1 reference

Development of secondary resistance to fluconazole in Cryptococcus neoformans isolated from a patient with AIDS.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762003000600022

In vitro susceptibility to antifungal agents of clinical and environmental Cryptococcus neoformans isolated in Southern of Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762003000600022

Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762003000600022

Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762003000600022

Fluconazole-resistant Cryptococcus neoformans var gattii in an AIDS patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762003000600022

Prospects for preventing cryptococcosis in persons infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762003000600022

Cryptococcal Meningitis in HIV-Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762003000600022

The hidden danger of primary fluconazole prophylaxis for patients with AIDS

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1590/S0074-02762003000600022

Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates

27 March 2024

10

1 reference

https://api.crossref.org/works/10.1590/S0074-02762003000600022

Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

27 March 2024

13

1 reference

https://api.crossref.org/works/10.1590/S0074-02762003000600022

Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies

27 March 2024

15

1 reference

https://api.crossref.org/works/10.1590/S0074-02762003000600022

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

27 March 2024

16

1 reference

https://api.crossref.org/works/10.1590/S0074-02762003000600022

Clinical epidemiological study of 171 cases of cryptococcosis

27 March 2024

25

1 reference

https://api.crossref.org/works/10.1590/S0074-02762003000600022

Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City

27 March 2024

26

1 reference

https://api.crossref.org/works/10.1590/S0074-02762003000600022

Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing

27 March 2024

28

1 reference

https://api.crossref.org/works/10.1590/S0074-02762003000600022

27 March 2024

Identifiers

1 reference

8 September 2017

1 reference